摘要
Peroxisome proliferator activated receptors： In the early 1990s, seminal work on rodent liver demonstrated that the hypolipidemic effect of xenobiotics, referred to as peroxisome proliferators, was mediated by a member of steroid hormone receptor superfamily, thus designated peroxisome proliferator-activated receptors （PPARs） （Issemann and Green, 1990; Dreyer et al., 1992）. The research field opened by this discovery led to the identification of three isotypes, namely PPARa （NR1C1）, PPAR[3/6 （NRIC2）, PPARy （NRIC3）, in a wide range of tissues. All these receptors act as ligand-activated transcription factors, binding lipid molecules with different, though overlapping, specificity.
Peroxisome proliferator activated receptors： In the early 1990s, seminal work on rodent liver demonstrated that the hypolipidemic effect of xenobiotics, referred to as peroxisome proliferators, was mediated by a member of steroid hormone receptor superfamily, thus designated peroxisome proliferator-activated receptors （PPARs） （Issemann and Green, 1990; Dreyer et al., 1992）. The research field opened by this discovery led to the identification of three isotypes, namely PPARa （NR1C1）, PPAR[3/6 （NRIC2）, PPARy （NRIC3）, in a wide range of tissues. All these receptors act as ligand-activated transcription factors, binding lipid molecules with different, though overlapping, specificity.
基金
supported by CAL grant to SM from University Roma Tre
